DR.
GAYATRI SABERWAL
My
group researches the bio-pharma and related health industries, both in India and abroad.
Such studies, both
quantitatve and qualitative, should prove useful to policy making that is
geared to supporting an innovative industry.
In addition we have a series of general articles in
Current Science entitled 'Bio-business in brief'. These articles
highlight different aspects of drug discovery and development, including institutional arrangements, that are possibly of interest to
scientists and policy researchers. We hope that they will contribute to a debate that is vital to producing a knowledge
driven industry, itself important to ensure a healthier India.
RELEVANT RESEARCH
PUBLICATIONS
Jaroslawski, S. and Saberwal, G.
Case studies of innovative medical device companies from India: Barriers and enablers to development.
BMC Health Services Research (in press)
Kumari, S. and Saberwal, G.
Patent
maintenence by Indian pharma and bio-pharma companies.
Asian Biotechnology Development Review (in press)
Saberwal, G.
Giving voice to India's entrepreneurs.
Nature Biotechnology, 31, 104-107 (2013)
Marimuthu, G., Kumari, S.,
Kandasamy, M., Raghunathan, S. and Saberwal, G.
Patents protecting biologics or small molecule drugs are usually
maintained.
Nature Biotechnology, 30, 50-53 (2012)
Soby, S, Sebastian, T.E. and
Saberwal, G.
US patent holdings of Indian non-corporate entities.
Asian Biotechnology Development Review, 14, 21-33 (2012)
Soby, S., Kandasamy, M. and
Saberwal, G
Work outsourced to Indian biotech and pharma companies is not yet
significantly innovative.
Current Science, 102, 401-404 (2012)
Sebastian, T.E., Pattnayak,
J.P., Soby, S and Saberwal, G.
Patent holdings of Indian pharmaceutical and biotechnology companies in
international markets of different sizes.
Asian Biotechnology Development Review, 13, 17-37 (2011)
Saberwal, G.
Seeding a skilled workforce.
Nature
Biotechnology, 27,
773-775 (2009)
Sebastian, T.E., Chandra Bindu,
Y. and Saberwal, G.
Patent holdings of US biotherapeutic companies in major markets.
Drug
Discovery Today,
14, 442-445 (2009)
Sundaramoorthy, S.,
Chandra Bindu, Y. , Mehdiratta, R. and Saberwal, G.
The US patent holdings of homegrown Indian biotech and pharma
companies.
Current
Science, 96, 252-259 (2009)
Parida, D.K,
Mehdiratta, R. and Saberwal, G.
How many patents does a bio-therapeutics company need?
Nature
Biotechnology, 26, 763-766 (2008)
Saberwal, G
New pharma-biotech company formation in India
Nature
Biotechnology,
24, 499-501 (2006)
SERIES OF ARTICLES IN CURRENT SCIENCE
Venkatachalam, S. and Saberwal, G
Bio-business in brief: A case for new drugs at generic prices from India
Current
Science, 102, 1375-1381 (2012)
Saberwal, G
Translating academic discoveries
Current
Science, 103, 767-769 (2012)
Saberwal, G
Bio-business in brief: A bit about technology transfer
Current
Science, 99, 177-180 (2010)
Saberwal, G
Bio-business in brief: The debate over biosimilars
Current
Science, 98, 1575-1578 (2010)
Saberwal, G
Bio-business in brief: The paradox of being a drug company
Current
Science,
97, 623-625
(2009)
Devaguptapu, S, Mehdiratta, R
and Saberwal, G
Bio-business in brief: The case of Cytokinetics Inc.
Current
Science, 94,
1576-1581 (2008)
Mehdiratta, R, Parida, D
K and Saberwal, G
Bio-business in brief: The challenges of clinical trials
Current
Science, 93,
1367-1375 (2007)
Mehdiratta, R and Saberwal, G
Bio-business in brief: Many a monoclonal.
Current
Science,
93, 789-796 (2007)
Mehdiratta, R and Saberwal, G
Bio-business in brief: The case of conotoxins.
Current
Science,
92, 39-45 (2007)
PERSPECTIVES AND OTHER
ARTICLES
Saberwal, G.
Caring for a severely disabled person.
Available here.
Kapoor, M. and Saberwal, G
The new crossroads
Biotech News, 5, 143-145 (2010).
Saberwal, G.
Drug development in India: What does the future look like?
Contemporary Perspectives: History and Sociology of South Asia,
Ed. N Tyabji, 3, 293-309
(2009)
Saberwal, G
A long march
Biotech
News, IV, 68-69 & 75 (2009)
Saberwal, G.
Biotechnology Incubation in India. In Business incubation:
Initiatives in India Ed. R. K. Lagu, brought out by NSTEDB, DST
(2004)
FUNDING
We have received generous
funding from the Wadhwani Foundation and the Institut Merieux to
support our research and
teaching.
